Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$31,270,547
+$12,960,934 QoQ
Shares Held
124,267
+47.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#474
of 4,167 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Intesa Sanpaolo S.p.A. holds $388,904,757 across 11 Drug Manufacturers - General names. ABBV ranks #2 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,469,097 | $278,570,173 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
124,267 | $31,270,547 | |
| 3 | LLY |
ELI LILLY & Co
|
19,008 | $22,798,767 | |
| 4 | JNJ |
Johnson & Johnson
|
73,501 | $18,667,048 | |
| 5 | PFE |
Pfizer Inc
|
701,043 | $16,881,115 | |
| 6 | MRK |
Merck & Co., Inc.
|
75,023 | $9,640,455 | |
| 7 | AMGN |
Amgen Inc
|
16,650 | $6,029,298 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
31,801 | $4,017,738 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,270,547 | 124,267 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $18,309,613 | 84,186 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,494,894 | 80,944 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||